Beijing Cancer Hospital of Peking University

Beijing 100142

0 studies enrolling now · 3 studies all time

What they study most

Castration-Resistant Prostatic Cancer, Hepatocellular Carcinoma, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer — Recruiting now
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer — Running, not enrolling
• T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients — Stopped early